Irvine, California
United States
64
2020-08-20
The entities that hold a legal rights for patent applications filed by inventor Robinson Michael R.:
Michael R. Robinson from Irvine, US has applied for patents for these inventions. The list has both pending applications and granted patents:
BIODEGRADABLE DRUG DELIVERY SYSTEMS FOR THE SUSTAINED RELEASE OF PROTEINS
#2 | 2020-04-23INTRACAMERAL SUSTAINED RELEASE THERAPEUTIC AGENT IMPLANTS
#3 | 2020-03-05Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
#4 | 2019-11-07METHOD FOR TREATING ATROPHIC AGE RELATED MACULAR DEGENERATION
#5 | 2019-08-22INTRACAMERAL SUSTAINED RELEASE THERAPEUTIC AGENT IMPLANTS
#6 | 2017-08-03Dermal filler
#7 | 2017-04-13Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
#8 | 2017-03-16Intracameral sustained release therapeutic agent implants
#9 | 2017-03-02Prostamide-containing intraocular implants and methods of use thereof
#10 | 2016-09-08SUSTAINED-RELEASE RESERVOIR IMPLANTS FOR INTRACAMERAL DRUG DELIVERY
#11 | 2016-07-14Prostamide-containing intraocular implant
#12 | 2016-02-11Dermal filler
#13 | 2016-02-04Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
#14 | 2015-10-08Intracameral sustained release therapeutic agent implants
#15 | 2015-08-27Intraocular implant delivery apparatus and methods of use thereof
#16 | 2015-06-25BIODEGRADABLE DRUG DELIVERY SYSTEM
#17 | 2015-05-28Intraocular Formulation
#18 | 2015-04-30Prostamide-containing intraocular implants and methods of use thereof
#19 | 2015-04-16SUSTAINED-RELEASE RESERVOIR IMPLANTS FOR INTRACAMERAL DRUG DELIVERY
#20 | 2015-03-19POLYMER SYSTEM FOR SECURING IMPLANTS IN SYRINGE NEEDLES
#21 | 2014-12-04Peripherally administered viscous formulations
#22 | 2014-11-20Intraocular Drug Delivery Systems
#23 | 2014-11-20STEROID-CONTAINING SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND RELATED METHODS
#24 | 2014-10-30Method for treating atrophic age related macular degeneration
#25 | 2014-10-23Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
#26 | 2014-10-09toxin formulation
#27 | 2014-09-18Prostamide-containing intraocular implant
#28 | 2014-03-27Biodegradable drug delivery systems for the sustained release of proteins
#29 | 2014-02-13Intracameral sustained release therapeutic agent implants
#30 | 2014-01-09METHOD FOR DETERMINING OPTIMUM INTRAOCULAR LOCATIONS FOR DRUG DELIVERY SYSTEMS
#31 | 2013-08-29MUTEINS OF HUMAN TEAR LIPCALIN FOR TREATING NEOVASCULAR DISEASE OF THE ANTERIOR SEGMENT OF THE HUMAN EYE
#32 | 2013-07-043-phenyl-5-ureidoisothiazole-4-carboximide and 3-amino-5-phenylisothiazole derivatives as kinase inhibitors
#33 | 2013-03-21BIODEGRADABLE POLYMERS FOR LOWERING INTRAOCULAR PRESSURE
#34 | 2013-02-14Pharmaceutical Formulations and Methods for Treating Ocular Conditions
#35 | 2013-01-17Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
#36 | 2013-01-17SUSTAINED-RELEASE RESERVOIR IMPLANTS FOR INTRACAMERAL DRUG DELIVERY
#37 | 2012-10-18Biodegradable drug delivery system
#38 | 2012-09-27INTRACAMERAL DEVICES FOR SUSTAINED DELIVERY
#39 | 2012-06-07Botulinum toxin formulation
#40 | 2011-07-28Intracameral sustained release therapeutic agent implants
#41 | 2010-11-04Intraocular pressure reduction with intracameral bimatoprost implants
#42 | 2010-09-30INTRAOCULAR SUSTAINED RELEASE DRUG DELIVERY SYSTEMS AND METHODS FOR TREATING OCULAR CONDITIONS
#43 | 2010-05-20Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
#44 | 2010-04-29PROSTAGLANDIN AND PROSTAMIDE DRUG DELIVERY SYSTEMS AND INTRAOCULAR THERAPEUTIC USES THEREOF
#45 | 2010-04-22DRUG DELIVERY SYSTEMS AND METHODS FOR TREATING NEOVASCULARIZATION
#46 | 2010-03-25INTRAOCULAR FORMULATION
#47 | 2010-01-21Method for treating atrophic age related macular degeneration
#48 | 2009-08-06STABILIZATION OF MITOCHONDRIAL MEMBRANES IN OCULAR DISEASES AND CONDITIONS
#49 | 2009-06-18Dermal filler
#50 | 2009-06-11INTRAOCULAR FORMULATION
#51 | 2009-06-04POLYSACCHARIDE GEL COMPOSITIONS AND METHODS FOR SUSTAINED DELIVERY OF DRUGS
#52 | 2009-03-26MODIFIED TENOTOMY SCISSORS WITH CONJUNCTIVA RISERS
#53 | 2009-03-26PHARMACEUTICAL FORMULATIONS AND METHODS FOR TREATING OCULAR CONDITIONS
#54 | 2009-01-01Use of an iris simulated layer to allow aesthetic appearance drug loaded contact lens
#55 | 2008-11-27Biodegradable drug delivery system
#56 | 2008-07-31Method for determining optimum intraocular locations for drug delivery systems
#57 | 2008-06-05Intraocular drug delivery systems
#58 | 2008-04-24OCULAR IMPLANT DELIVERY ASSEMBLIES
#59 | 2008-02-21Peripherally administered viscous formulations
#60 | 2008-02-07Ocular implant delivery assemblies with distal caps
#61 | 2007-12-27Steroid-containing sustained release intraocular implants and related methods
#62 | 2007-12-27Steroid-containing sustained release intraocular implants and related methods
#63 | 2007-09-27LOW IMMUNOGENICITY CORTICOSTEROID COMPOSITIONS
#64 | 2007-08-16OCULAR THERAPEUTIC AGENT DELIVERY DEVICES AND METHODS FOR MAKING AND USING SUCH DEVICES
40360 ⎘